Hepcidin is potential regulator for renin activity

Area of Science:

• Biochemistry
• Physiology
• Genetics

Background:

• Genetic variants in HFE, HJV, and BMP4 genes are linked to arterial hypertension.
• These genes influence hepcidin production, a peptide hormone.
• Hepcidin's role in regulating blood pressure via the renin-angiotensin system is under investigation.

Purpose of the Study:

• To investigate hepcidin's potential to bind and inhibit renin, a critical enzyme in blood pressure regulation.
• To explore hepcidin's interaction with other renin-angiotensin system enzymes, including angiotensin converting enzymes 1 and 2.

Main Methods:

• Molecular modeling to predict hepcidin binding to the renin active site.
• Fluorometric assays to assess hepcidin's inhibitory effects on renin and angiotensin converting enzymes.
• Bio-layer interferometry to confirm and quantify hepcidin-renin binding.

Main Results:

• Molecular modeling suggested hepcidin shares binding characteristics with angiotensinogen at the renin active site.
• In vitro assays demonstrated hepcidin's inhibitory effect on renin activity.
• Hepcidin showed minimal inhibition of angiotensin converting enzymes 1 and 2; binding to renin was concentration-dependent.

Conclusions:

• Hepcidin exhibits inhibitory effects on renin, suggesting a potential role in blood pressure regulation.
• The findings indicate hepcidin as a possible endogenous inhibitor of renin.
• This discovery holds potential clinical significance for managing hypertension.